Cosmos Health (NASDAQ:COSM) CFO Purchases $42,033.75 in Stock

Cosmos Health Inc. (NASDAQ:COSM) CFO Georgios Terzis bought 168,135 shares of the firm’s stock in a transaction that occurred on Tuesday, June 16th. The stock was purchased at an average cost of $0.25 per share, for a total transaction of $42,033.75. Following the completion of the purchase, the chief financial officer owned 2,235,398 shares of the company’s stock, valued at $558,849.50. This trade represents a 8.13% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Cosmos Health Stock Performance

NASDAQ:COSM opened at $0.21 on Friday. The company has a fifty day moving average of $0.30 and a 200 day moving average of $0.38. Cosmos Health Inc. has a 52 week low of $0.18 and a 52 week high of $1.32. The company has a quick ratio of 0.92, a current ratio of 1.08 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $13.22 million, a P/E ratio of -0.33 and a beta of 4.79.

Cosmos Health (NASDAQ:COSM) last announced its quarterly earnings results on Thursday, May 21st. The company reported ($0.06) earnings per share for the quarter, meeting the consensus estimate of ($0.06). The business had revenue of $18.40 million during the quarter, compared to analysts’ expectations of $17.93 million. Cosmos Health had a negative net margin of 30.41% and a negative return on equity of 52.85%. On average, research analysts predict that Cosmos Health Inc. will post -0.06 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Cosmos Health in a report on Monday. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Hedge Funds Weigh In On Cosmos Health

Institutional investors and hedge funds have recently modified their holdings of the company. XTX Topco Ltd increased its position in shares of Cosmos Health by 52.1% during the 4th quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock valued at $50,000 after purchasing an additional 34,117 shares during the last quarter. Renaissance Technologies LLC lifted its stake in shares of Cosmos Health by 260.5% in the 4th quarter. Renaissance Technologies LLC now owns 334,575 shares of the company’s stock worth $167,000 after purchasing an additional 241,775 shares during the period. Finally, Citadel Advisors LLC boosted its holdings in shares of Cosmos Health by 133.1% in the third quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock worth $250,000 after buying an additional 128,776 shares during the last quarter. 12.61% of the stock is currently owned by hedge funds and other institutional investors.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.